ARTA
ZSAN

A.R.T. Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

A.R.T. Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-717
Closed -$21K – 301
2020
Q2 		$21K Buy
+717
New +$20.2K 0.03% 256
2019
Q4 		– Sell
-489
Closed -$27K – 1857
2019
Q3 		$27K Buy
+489
New +$43.8K ﹤0.01% 1358

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's ZSAN Position: Q3 2020 in Review

A.R.T. Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q3 2020, closing a stake of 717 shares — an estimated $21K sold.

A.R.T. Advisors first reported a position in ZSAN in Q3 2019 and held it in 2 quarters. The position peaked at $27K in Q3 2019. 43 funds tracked by Wall St. Rank hold ZSAN as of Q3 2020.

  • A.R.T. Advisors reported no remaining Zosano Pharma Corporation position as of Q3 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 717 Zosano Pharma Corporation shares in Q3 2020, an estimated $21K.
  • A.R.T. Advisors first reported a position in Zosano Pharma Corporation in Q3 2019 and held it in 2 quarters.
  • A.R.T. Advisors's Zosano Pharma Corporation position peaked at $27K in Q3 2019.
  • 43 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.